{"blog": [], "keywords": [{"value": "Blood Donation", "name": "subject", "rank": "1", "is_major": "N"}, {"value": "Homosexuality and Bisexuality", "name": "subject", "rank": "2", "is_major": "N"}, {"value": "Discrimination", "name": "subject", "rank": "3", "is_major": "N"}, {"value": "Food and Drug Administration", "name": "organizations", "rank": "4", "is_major": "N"}, {"value": "Marks, Peter", "name": "persons", "rank": "5", "is_major": "N"}], "web_url": "http://www.nytimes.com/2015/05/28/opinion/fda-blood-donor-policy.html", "document_type": "article", "byline": [], "type_of_material": "Letter", "multimedia": [], "section_name": "Opinion", "word_count": "254", "source": "The New York Times", "subsection_name": null, "lead_paragraph": "The Food and Drug Administration discusses its proposed one-year deferral policy for gay men.", "pub_date": "2015-05-28T00:00:00Z", "news_desk": "Letters", "headline": {"kicker": "Letter", "print_headline": "F.D.A. Blood Donor Policy", "main": "F.D.A. Blood Donor Policy", "content_kicker": "Letter"}, "print_page": "24", "snippet": "The Food and Drug Administration discusses its proposed one-year deferral policy for gay men.", "_id": "5566c1e038f0d86f0b8504b6", "slideshow_credits": null, "abstract": null}